Sotera Health Company (SHC)
| Previous Close | 16.13 |
| Open | 16.83 |
| Bid | 15.86 x 300 |
| Ask | 15.95 x 100 |
| Day's Range | 15.85 - 16.16 |
| 52 Week Range | 10.71 - 17.44 |
| Volume | |
| Avg. Volume | 1,292,372 |
| Market Cap | 4.503B |
| Beta (5Y Monthly) | 2.07 |
| PE Ratio (TTM) | 113.57 |
| EPS (TTM) | 0.14 |
| Earnings Date | Oct 30, 2024 - Nov 04, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 16.75 |
Investor's Business DailySotera Health Stock Earns 91 RS Rating
On Tuesday, Sotera Health hit an important technical milestone, with its Relative Strength (RS) Rating climbing into the 90-plus percentile with an upgrade to 91, a rise from 86 the day before. This unique rating measures technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price performance over the trailing 52 weeks matches up against other publicly traded companies.
Simply Wall St.Top 3 US Stocks Estimated To Be Trading Below Fair Value In September 2024
As the U.S. stock market faces a period of uncertainty with the S&P 500 falling for three consecutive days and investors anxiously awaiting critical economic data, identifying undervalued stocks becomes increasingly important. In this environment, stocks trading below their fair value present potential opportunities for investors looking to capitalize on market inefficiencies.
GlobeNewswireSotera Health Announces Secondary Offering of Common Stock
CLEVELAND, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share. All 25,000,000 shares are being offered for sale by certain affiliates of Warburg Pincus LLC (“Warburg Pincus”) and GTCR LLC (“GTCR”) as selling stockholders. No other entities, and no individuals, are selling shares in the Offering. It is expected that, as a resul
